Jeremy Shapiro
Monash University
H-index: 37
Oceania-Australia
Top articles of Jeremy Shapiro
Carboplatin in Metastatic Castrate Resistant Prostate Cancer: A retrospective study of heavily pre-treated patients (COMPACT)
Clinical Genitourinary Cancer
2024/1/22
Jeremy Shapiro
H-Index: 24
Circulating tumor DNA analysis informing adjuvant chemotherapy in locally advanced rectal cancer: The randomized AGITG DYNAMIC-Rectal study.
2024/1/20
The association of healthcare contact days with physical function and survival in CCTG/AGITG CO. 17
JNCI: Journal of the National Cancer Institute
2024/4/24
A practical guide for the use of apalutamide for non‐metastatic castration‐resistant prostate cancer in Australia
2024/4/19
Jeremy Shapiro
H-Index: 24
Transverse Colon Primary Tumor Location as a Biomarker in Metastatic Colorectal Cancer: A Pooled Analysis of CCTG/AGITG CO. 17 and CO. 20 Randomized Clinical Trials
Clinical Cancer Research
2024/1/30
Impact of neoadjuvant FOLFIRINOX over upfront resection in borderline resectable pancreatic cancer—an international, multicentre, real-world analysis
ESMO Real World Data and Digital Oncology
2024/3/1
Plasma Cetuximab Concentrations Correlate With Survival in Patients With Advanced KRAS Wild Type Colorectal Cancer
Clinical Colorectal Cancer
2023/12/1
117P Australasian real-world treatment selection and clinical outcomes for patients with left side (LS), RAS wildtype (RASwt) metastatic colorectal cancer (mCRC)
Annals of Oncology
2023/11/1
634P The ave-rec phase II trial of PD-L1/PD-1 blockade with avelumab plus chemoradiotherapy for resectable ESMO high risk rectal cancers
Annals of Oncology
2023/10/1
Rucaparib for the treatment of metastatic castration-resistant prostate cancer associated with a DNA damage repair gene alteration: final results from the phase 2 TRITON2 study
European urology
2023/9/1
Compliance with Therapeutic Goods Association prescribing information: weekly or second weekly cetuximab for the treatment of metastatic colorectal cancer
Internal Medicine Journal
2023/9
Clinical and metabolomic characterization of Brivanib‐Induced hypertension in metastatic colorectal cancer
Cancer Medicine
2023/8
A Bayesian approach for two‐stage multivariate Mendelian randomization with mixed outcomes
Statistics in Medicine
2023/6/15
Yangqing Deng
H-Index: 4
Dongsheng Tu
H-Index: 48
Jeremy Shapiro
H-Index: 24
Geoffrey Liu
H-Index: 4
Wei Xu
H-Index: 19
The Ave-Rec trial: Phase II trial of PD-L1/PD-1 blockade with avelumab plus chemoradiotherapy for locally advanced resectable T3B-4/N1-2 rectal cancer—Toxicity and interim …
2023/6/1
Evaluating the time toxicity of cancer treatment in the CCTG CO. 17 trial
JCO Oncology Practice
2023/6
Adjuvant nab-paclitaxel+ gemcitabine in resected pancreatic ductal adenocarcinoma: results from a randomized, open-label, phase III trial
Journal of Clinical Oncology
2023/4/4
Clustering on longitudinal quality‐of‐life measurements using growth mixture models for clinical prognosis: Implementation on CCTG/AGITG CO. 20 trial
Cancer Medicine
2023/3
Emergence of BRCA reversion mutations in patients with metastatic castration-resistant prostate cancer after treatment with rucaparib
European urology
2023/3/1
Arif Hussain
H-Index: 3
Jeremy Shapiro
H-Index: 24
Francesco Ricci
H-Index: 14
Simon Watkins
H-Index: 13
Minh Nguyen
H-Index: 1
Predictive and prognostic features of metastatic colorectal cancer arising from the transverse colon: A pooled analysis of the CCTG/AGITG CO. 17 and CO. 20 randomized trials.
2023/2/1
Use and outcomes from neoadjuvant chemotherapy in borderline resectable pancreatic ductal adenocarcinoma in an Australasian population
Asia‐Pacific Journal of Clinical Oncology
2023/2
